Haemophagocytic lymphohistiocytosis: vizsgálatok itt: Egyesült Államok

In Egyesült Államok 11 Also abroad 35

11 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.

No phaseTaking people
Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study
Where
Bethesda, Pittsburgh
Életkor
18 év to 120 év
People
300
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT06339177
No phaseNot yet taking people in Egyesült Államok
Long Term Safety Study in Patients With HLH/MAS in Still's Disease Exposed to Gamifant.
Where
Ann Arbor, Atlanta, Birmingham, Boston, Charlotte, Cincinnati, Columbus, Dallas, Houston, Los Angeles, Miami, Minneapolis, New York, Philadelphia, Pittsburgh, Seattle, St. Petersburg
Életkor
Up to 80 év
People
70
Run by
Swedish Orphan Biovitrum
See details and how to joinNCT07909005
No phaseTaking people
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Where
Sioux Falls
People
20 000
Run by
Sanford Health
See details and how to joinNCT01793168
2/3. fázisTaking people
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Where
Atlanta, Birmingham, Cleveland, Dallas, Houston, Los Angeles, New York, Philadelphia, Phoenix, Rockville, Salt Lake City, Seattle, St. Petersburg, Washington D.C.
Életkor
6 év and over
People
156 worldwide
Run by
Electra Therapeutics Inc.
See details and how to joinNCT05416307
2. fázisTaking people
Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)
Where
Irvine, Sacramento, San Diego, San Francisco
Életkor
18 év and over
People
54
Run by
Jerry Lee, MD, MSc, MPhil
See details and how to joinNCT06160791
1. fázisTaking people
Ruxolitinib for Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (RISE)
Where
Baltimore
Életkor
18 év to 99 év
People
16
Run by
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT07424222
2. fázisNot yet taking people in Egyesült Államok
Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases
Where
Seattle
Életkor
6 hónap to 50 év
People
40
Run by
Fred Hutchinson Cancer Center
See details and how to joinNCT07660783
No phaseTaking people
INTO-HLH: A Disease Registry for Patients With Hemophagocytic Lymphohistiocytosis (HLH)
Where
Cincinnati
People
200
Run by
Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT05277272
No phaseTaking people
Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis
Where
Birmingham
People
2000
Run by
University of Alabama at Birmingham
See details and how to joinNCT05898477
No phaseTaking people
Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Where
Pittsburgh
Életkor
2 hónap to 60 év
People
50
Run by
Paul Szabolcs
See details and how to joinNCT04528355
2. fázisTaking people
Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Where
Pittsburgh
Életkor
2 hónap to 55 év
People
100
Run by
Paul Szabolcs
See details and how to joinNCT01962415